Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DOC1021 |
Synonyms | |
Therapy Description |
DOC1021 is a cancer vaccine comprising autologous dendritic cells loaded with autologous tumor lysate and amplified mRNA, which potentially enhances antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DOC1021 | DOC-1021|DOC 1021 | DOC1021 is a cancer vaccine comprising autologous dendritic cells loaded with autologous tumor lysate and amplified mRNA, which potentially enhances antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|